-
Je něco špatně v tomto záznamu ?
Nitric oxide synthases activation and inhibition by metallacarborane-cluster-based isoform-specific affectors
R. Kaplánek, P. Martásek, B. Grüner, S. Panda, J. Rak, BS. Masters, V. Král, LJ. Roman,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
PubMed
23075390
DOI
10.1021/jm300805x
Knihovny.cz E-zdroje
- MeSH
- chemické modely MeSH
- kobalt chemie MeSH
- lidé MeSH
- molekulární struktura MeSH
- organokovové sloučeniny chemická syntéza farmakologie MeSH
- protein - isoformy MeSH
- sloučeniny boru chemická syntéza farmakologie MeSH
- synthasa oxidu dusnatého antagonisté a inhibitory metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
A small library of boron-cluster- and metallacarborane-cluster-based ligands was designed, prepared, and tested for isoform-selective activation or inhibition of the three nitric oxide synthase isoforms. On the basis of the concept of creating a hydrophobic analogue of a natural substrate, a stable and nontoxic basic boron cluster system, previously used for boron neutron capture therapy, was modified by the addition of positively charged moieties to its periphery, providing hydrophobic and nonclassical hydrogen bonding interactions with the protein. Several of these compounds show efficacy for inhibition of NO synthesis with differential effects on the various nitric oxide synthase isoforms.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13012390
- 003
- CZ-PrNML
- 005
- 20130411113202.0
- 007
- ta
- 008
- 130404s2012 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/jm300805x $2 doi
- 035 __
- $a (PubMed)23075390
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kaplánek, Robert $u Department of Analytical Chemistry, Institute of Chemical Technology in Prague, Technická 5, 166 28 Prague 6, Czech Republic.
- 245 10
- $a Nitric oxide synthases activation and inhibition by metallacarborane-cluster-based isoform-specific affectors / $c R. Kaplánek, P. Martásek, B. Grüner, S. Panda, J. Rak, BS. Masters, V. Král, LJ. Roman,
- 520 9_
- $a A small library of boron-cluster- and metallacarborane-cluster-based ligands was designed, prepared, and tested for isoform-selective activation or inhibition of the three nitric oxide synthase isoforms. On the basis of the concept of creating a hydrophobic analogue of a natural substrate, a stable and nontoxic basic boron cluster system, previously used for boron neutron capture therapy, was modified by the addition of positively charged moieties to its periphery, providing hydrophobic and nonclassical hydrogen bonding interactions with the protein. Several of these compounds show efficacy for inhibition of NO synthesis with differential effects on the various nitric oxide synthase isoforms.
- 650 _2
- $a sloučeniny boru $x chemická syntéza $x farmakologie $7 D001896
- 650 _2
- $a kobalt $x chemie $7 D003035
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a chemické modely $7 D008956
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a synthasa oxidu dusnatého $x antagonisté a inhibitory $x metabolismus $7 D019001
- 650 _2
- $a organokovové sloučeniny $x chemická syntéza $x farmakologie $7 D009942
- 650 _2
- $a protein - isoformy $7 D020033
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Martásek, Pavel $u -
- 700 1_
- $a Grüner, Bohumír $u -
- 700 1_
- $a Panda, Satya $u -
- 700 1_
- $a Rak, Jakub $u -
- 700 1_
- $a Masters, Bettie Sue Siler $u -
- 700 1_
- $a Král, Vladimír $u -
- 700 1_
- $a Roman, Linda J $u -
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 55, č. 22 (2012), s. 9541-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23075390 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130404 $b ABA008
- 991 __
- $a 20130411113432 $b ABA008
- 999 __
- $a ok $b bmc $g 975588 $s 810671
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 55 $c 22 $d 9541-8 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- LZP __
- $a Pubmed-20130404